25 XP   0   0   10

Aspira Pathlab & Diagnostics Ltd
Buy, Hold or Sell?

Let's analyse Aspira Pathlab & Diagnostics Ltd together

PenkeI guess you are interested in Aspira Pathlab & Diagnostics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aspira Pathlab & Diagnostics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Aspira Pathlab & Diagnostics Ltd

I send you an email if I find something interesting about Aspira Pathlab & Diagnostics Ltd.

Quick analysis of Aspira Pathlab & Diagnostics Ltd (30 sec.)










What can you expect buying and holding a share of Aspira Pathlab & Diagnostics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR12.39
Expected worth in 1 year
INR12.24
How sure are you?
57.1%

+ What do you gain per year?

Total Gains per Share
INR-0.15
Return On Investment
-0.5%

For what price can you sell your share?

Current Price per Share
INR31.00
Expected price per share
INR22.76 - INR43.95
How sure are you?
50%

1. Valuation of Aspira Pathlab & Diagnostics Ltd (5 min.)




Live pricePrice per Share (EOD)

INR31.00

Intrinsic Value Per Share

INR23.09 - INR117.39

Total Value Per Share

INR35.47 - INR129.78

2. Growth of Aspira Pathlab & Diagnostics Ltd (5 min.)




Is Aspira Pathlab & Diagnostics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5m$1.5m-$4.6k-0.3%

How much money is Aspira Pathlab & Diagnostics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$10.6k$535.1k-$545.7k-5,127.5%
Net Profit Margin-0.6%22.8%--

How much money comes from the company's main activities?

3. Financial Health of Aspira Pathlab & Diagnostics Ltd (5 min.)




What can you expect buying and holding a share of Aspira Pathlab & Diagnostics Ltd? (5 min.)

Welcome investor! Aspira Pathlab & Diagnostics Ltd's management wants to use your money to grow the business. In return you get a share of Aspira Pathlab & Diagnostics Ltd.

What can you expect buying and holding a share of Aspira Pathlab & Diagnostics Ltd?

First you should know what it really means to hold a share of Aspira Pathlab & Diagnostics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Aspira Pathlab & Diagnostics Ltd is INR31.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aspira Pathlab & Diagnostics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aspira Pathlab & Diagnostics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR12.39. Based on the TTM, the Book Value Change Per Share is INR-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is INR4.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aspira Pathlab & Diagnostics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.000.0%0.000.0%0.050.2%-0.010.0%-0.04-0.1%
Usd Book Value Change Per Share0.000.0%0.000.0%0.050.2%0.030.1%0.020.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.050.2%0.030.1%0.020.1%
Usd Price Per Share0.52-0.52-0.93-0.35-0.25-
Price to Earnings Ratio-499.56--499.56-17.81--92.36--65.97-
Price-to-Total Gains Ratio-1,133.28--1,133.28-17.75--369.61--369.61-
Price to Book Ratio3.48-3.48-6.21-2.60-1.86-
Price-to-Total Gains Ratio-1,133.28--1,133.28-17.75--369.61--369.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.372
Number of shares2688
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.03
Usd Total Gains Per Share0.000.03
Gains per Quarter (2688 shares)-1.2375.75
Gains per Year (2688 shares)-4.90303.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5-150303293
20-10-200606596
30-15-250909899
40-20-30012121202
50-25-35015151505
60-29-40018181808
70-34-45021212111
80-39-50024242414
90-44-55027272717
100-49-60030303020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%2.05.00.028.6%2.05.00.028.6%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.03.00.057.1%4.03.00.057.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.03.00.057.1%4.03.00.057.1%

Fundamentals of Aspira Pathlab & Diagnostics Ltd

About Aspira Pathlab & Diagnostics Ltd

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Aspira Pathlab & Diagnostics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aspira Pathlab & Diagnostics Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • A Net Profit Margin of -0.6% means that ₹-0.01 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is -0.6%. The company is not making a profit/loss.
  • The TTM is -0.6%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-0.6%0.0%
TTM-0.6%YOY22.8%-23.4%
TTM-0.6%5Y-17.4%+16.8%
5Y-17.4%10Y-82.0%+64.6%
1.1.2. Return on Assets

Shows how efficient Aspira Pathlab & Diagnostics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • -0.5% Return on Assets means that Aspira Pathlab & Diagnostics Ltd generated ₹-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is -0.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.5%TTM-0.5%0.0%
TTM-0.5%YOY24.6%-25.1%
TTM-0.5%5Y-5.8%+5.2%
5Y-5.8%10Y-13.1%+7.3%
1.1.3. Return on Equity

Shows how efficient Aspira Pathlab & Diagnostics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • -0.7% Return on Equity means Aspira Pathlab & Diagnostics Ltd generated ₹-0.01 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.7%TTM-0.7%0.0%
TTM-0.7%YOY34.9%-35.6%
TTM-0.7%5Y-32.1%+31.4%
5Y-32.1%10Y-267.7%+235.6%

1.2. Operating Efficiency of Aspira Pathlab & Diagnostics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aspira Pathlab & Diagnostics Ltd is operating .

  • Measures how much profit Aspira Pathlab & Diagnostics Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Aspira Pathlab & Diagnostics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are ₹1.17 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 1.172. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.172. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.172TTM1.1720.000
TTM1.172YOY0.901+0.271
TTM1.1725Y1.327-0.154
5Y1.32710Y1.031+0.296

1.3. Liquidity of Aspira Pathlab & Diagnostics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aspira Pathlab & Diagnostics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 3.70 means the company has ₹3.70 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 3.695. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.695. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.695TTM3.6950.000
TTM3.695YOY3.994-0.299
TTM3.6955Y2.161+1.534
5Y2.16110Y1.799+0.363
1.3.2. Quick Ratio

Measures if Aspira Pathlab & Diagnostics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • A Quick Ratio of 4.10 means the company can pay off ₹4.10 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 4.097. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.097. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.097TTM4.0970.000
TTM4.097YOY3.591+0.506
TTM4.0975Y2.000+2.097
5Y2.00010Y1.551+0.449

1.4. Solvency of Aspira Pathlab & Diagnostics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aspira Pathlab & Diagnostics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to industry mean.
  • A Debt to Asset Ratio of 0.26 means that Aspira Pathlab & Diagnostics Ltd assets are financed with 26.5% credit (debt) and the remaining percentage (100% - 26.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 0.265. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.265. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.265TTM0.2650.000
TTM0.265YOY0.295-0.030
TTM0.2655Y0.448-0.183
5Y0.44810Y0.545-0.097
1.4.2. Debt to Equity Ratio

Measures if Aspira Pathlab & Diagnostics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • A Debt to Equity ratio of 36.0% means that company has ₹0.36 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 0.360. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.360. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.360TTM0.3600.000
TTM0.360YOY0.418-0.058
TTM0.3605Y1.163-0.803
5Y1.16310Y6.251-5.088

2. Market Valuation of Aspira Pathlab & Diagnostics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Aspira Pathlab & Diagnostics Ltd generates.

  • Above 15 is considered overpriced but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • A PE ratio of -499.56 means the investor is paying ₹-499.56 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The EOD is -359.733. Based on the earnings, the company is expensive. -2
  • The MRQ is -499.564. Based on the earnings, the company is expensive. -2
  • The TTM is -499.564. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-359.733MRQ-499.564+139.832
MRQ-499.564TTM-499.5640.000
TTM-499.564YOY17.807-517.372
TTM-499.5645Y-92.364-407.201
5Y-92.36410Y-65.974-26.390
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The EOD is -215.015. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -298.594. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -298.594. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-215.015MRQ-298.594+83.579
MRQ-298.594TTM-298.5940.000
TTM-298.594YOY55.766-354.360
TTM-298.5945Y-47.542-251.052
5Y-47.54210Y-33.958-13.583
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aspira Pathlab & Diagnostics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 3.48 means the investor is paying ₹3.48 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The EOD is 2.503. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.475. Based on the equity, the company is fair priced.
  • The TTM is 3.475. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.503MRQ3.475-0.973
MRQ3.475TTM3.4750.000
TTM3.475YOY6.209-2.734
TTM3.4755Y2.599+0.876
5Y2.59910Y1.857+0.743
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Aspira Pathlab & Diagnostics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.038-0.0380%4.348-101%2.349-102%1.770-102%
Book Value Per Share--12.38712.3870%12.4250%8.663+43%7.908+57%
Current Ratio--3.6953.6950%3.994-7%2.161+71%1.799+105%
Debt To Asset Ratio--0.2650.2650%0.295-10%0.448-41%0.545-51%
Debt To Equity Ratio--0.3600.3600%0.418-14%1.163-69%6.251-94%
Dividend Per Share----0%-0%-0%-0%
Eps---0.086-0.0860%4.332-102%-1.060+1130%-3.043+3431%
Free Cash Flow Per Share---0.144-0.1440%1.383-110%-0.071-51%-3.962+2648%
Free Cash Flow To Equity Per Share---1.053-1.0530%0.070-1605%0.613-272%0.771-237%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--117.389--------
Intrinsic Value_10Y_min--23.087--------
Intrinsic Value_1Y_max--4.236--------
Intrinsic Value_1Y_min--0.536--------
Intrinsic Value_3Y_max--18.463--------
Intrinsic Value_3Y_min--3.159--------
Intrinsic Value_5Y_max--39.608--------
Intrinsic Value_5Y_min--7.460--------
Market Cap--443113650.000443113650.0000%794104950.000-44%302511270.000+46%216079478.571+105%
Net Profit Margin---0.006-0.0060%0.228-103%-0.174+2735%-0.820+13268%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.1721.1720%0.901+30%1.327-12%1.031+14%
Pb Ratio2.503-39%3.4753.4750%6.209-44%2.599+34%1.857+87%
Pe Ratio-359.733+28%-499.564-499.5640%17.807-2905%-92.364-82%-65.974-87%
Price Per Share31.000-39%43.05043.0500%77.150-44%29.390+46%20.993+105%
Price To Free Cash Flow Ratio-215.015+28%-298.594-298.5940%55.766-635%-47.542-84%-33.958-89%
Price To Total Gains Ratio-816.069+28%-1133.283-1133.2830%17.745-6486%-369.610-67%-369.610-67%
Quick Ratio--4.0974.0970%3.591+14%2.000+105%1.551+164%
Return On Assets---0.005-0.0050%0.246-102%-0.058+1026%-0.131+2461%
Return On Equity---0.007-0.0070%0.349-102%-0.321+4518%-2.677+38381%
Total Gains Per Share---0.038-0.0380%4.348-101%2.349-102%1.770-102%
Usd Book Value--1530048.0001530048.0000%1534740.0000%1028322.072+49%841674.429+82%
Usd Book Value Change Per Share--0.0000.0000%0.052-101%0.028-102%0.021-102%
Usd Book Value Per Share--0.1490.1490%0.1490%0.104+43%0.095+57%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.0010%0.052-102%-0.013+1130%-0.037+3431%
Usd Free Cash Flow---17808.000-17808.0000%170880.000-110%20193.554-188%-229349.518+1188%
Usd Free Cash Flow Per Share---0.002-0.0020%0.017-110%-0.001-51%-0.048+2648%
Usd Free Cash Flow To Equity Per Share---0.013-0.0130%0.001-1605%0.007-272%0.009-237%
Usd Market Cap--5317363.8005317363.8000%9529259.400-44%3630135.240+46%2592953.743+105%
Usd Price Per Share0.372-39%0.5170.5170%0.926-44%0.353+46%0.252+105%
Usd Profit---10644.000-10644.0000%535128.000-102%-88124.136+728%-205352.126+1829%
Usd Revenue--1734828.0001734828.0000%2345028.000-26%1566185.640+11%1206416.314+44%
Usd Total Gains Per Share--0.0000.0000%0.052-101%0.028-102%0.021-102%
 EOD+3 -3MRQTTM+0 -0YOY+7 -255Y+20 -1210Y+22 -10

3.2. Fundamental Score

Let's check the fundamental score of Aspira Pathlab & Diagnostics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-359.733
Price to Book Ratio (EOD)Between0-12.503
Net Profit Margin (MRQ)Greater than0-0.006
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.097
Current Ratio (MRQ)Greater than13.695
Debt to Asset Ratio (MRQ)Less than10.265
Debt to Equity Ratio (MRQ)Less than10.360
Return on Equity (MRQ)Greater than0.15-0.007
Return on Assets (MRQ)Greater than0.05-0.005
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Aspira Pathlab & Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.165
Ma 20Greater thanMa 5032.490
Ma 50Greater thanMa 10033.398
Ma 100Greater thanMa 20036.031
OpenGreater thanClose34.750
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets173,417
Total Liabilities45,913
Total Stockholder Equity127,504
 As reported
Total Liabilities 45,913
Total Stockholder Equity+ 127,504
Total Assets = 173,417

Assets

Total Assets173,417
Total Current Assets58,564
Long-term Assets114,853
Total Current Assets
Cash And Cash Equivalents 17,828
Short-term Investments 18,056
Net Receivables 23,385
Other Current Assets 1,605
Total Current Assets  (as reported)58,564
Total Current Assets  (calculated)60,874
+/- 2,310
Long-term Assets
Property Plant Equipment 53,130
Goodwill 26,518
Intangible Assets 440
Other Assets -1
Long-term Assets  (as reported)114,853
Long-term Assets  (calculated)80,087
+/- 34,766

Liabilities & Shareholders' Equity

Total Current Liabilities15,848
Long-term Liabilities30,065
Total Stockholder Equity127,504
Total Current Liabilities
Accounts payable 3,450
Other Current Liabilities 1,059
Total Current Liabilities  (as reported)15,848
Total Current Liabilities  (calculated)4,509
+/- 11,339
Long-term Liabilities
Long term Debt Total 26,387
Long-term Liabilities  (as reported)30,065
Long-term Liabilities  (calculated)26,387
+/- 3,678
Total Stockholder Equity
Common Stock102,930
Retained Earnings 24,574
Total Stockholder Equity (as reported)127,504
Total Stockholder Equity (calculated)127,504
+/-0
Other
Capital Stock102,930
Cash And Equivalents5,666
Cash and Short Term Investments 23,494
Common Stock Shares Outstanding 10,293
Liabilities and Stockholders Equity 173,417
Net Debt 3,952
Net Invested Capital 137,122
Net Working Capital 42,716
Property Plant and Equipment Gross 53,130



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
148,572
125,319
147,998
143,353
117,758
181,353
173,417
173,417181,353117,758143,353147,998125,319148,572
   > Total Current Assets 
39,766
17,892
22,990
32,883
38,801
71,442
58,564
58,56471,44238,80132,88322,99017,89239,766
       Cash And Cash Equivalents 
0
0
936
10,000
11,834
2,893
17,828
17,8282,89311,83410,00093600
       Short-term Investments 
0
0
0
10,000
2,755
2,893
18,056
18,0562,8932,75510,000000
       Net Receivables 
870
3,548
7,961
6,046
17,027
44,911
23,385
23,38544,91117,0276,0467,9613,548870
       Inventory 
1,191
3,694
2,801
2,765
3,667
4,045
3,989
3,9894,0453,6672,7652,8013,6941,191
       Other Current Assets 
4,787
1,978
2,026
2,386
662
914
1,605
1,6059146622,3862,0261,9784,787
   > Long-term Assets 
0
0
125,008
110,470
78,957
109,911
114,853
114,853109,91178,957110,470125,00800
       Property Plant Equipment 
69,395
68,520
61,893
60,361
49,551
68,242
53,130
53,13068,24249,55160,36161,89368,52069,395
       Goodwill 
9,424
9,424
26,518
26,518
26,518
26,518
26,518
26,51826,51826,51826,51826,5189,4249,424
       Intangible Assets 
1,526
1,109
556
78
1,454
974
440
4409741,454785561,1091,526
       Long-term Assets Other 
0
0
0
1
2
-1
-1
-1-121000
> Total Liabilities 
89,411
121,971
96,083
105,344
34,613
53,458
45,913
45,91353,45834,613105,34496,083121,97189,411
   > Total Current Liabilities 
57,513
16,367
42,096
51,214
20,112
17,887
15,848
15,84817,88720,11251,21442,09616,36757,513
       Short-term Debt 
36,105
854
19,649
23,183
0
0
0
00023,18319,64985436,105
       Short Long Term Debt 
0
0
28,087
31,974
4,839
0
0
004,83931,97428,08700
       Accounts payable 
0
0
2,881
4,010
6,649
6,096
3,450
3,4506,0966,6494,0102,88100
       Other Current Liabilities 
0
0
0
392
783
-2
1,059
1,059-2783392000
   > Long-term Liabilities 
0
0
53,987
54,130
14,501
35,572
30,065
30,06535,57214,50154,13053,98700
       Long term Debt Total 
31,750
105,031
47,836
51,935
12,522
32,746
26,387
26,38732,74612,52251,93547,836105,03131,750
       Capital Lease Obligations Min Short Term Debt
-36,105
-854
-19,649
-11,904
8,338
30,631
23,517
23,51730,6318,338-11,904-19,649-854-36,105
> Total Stockholder Equity
59,161
3,348
51,915
38,009
83,145
127,895
127,504
127,504127,89583,14538,00951,9153,34859,161
   Common Stock
51,930
51,930
81,930
92,930
102,930
102,930
102,930
102,930102,930102,93092,93081,93051,93051,930
   Retained Earnings 
7,231
-48,582
-30,015
-54,921
-19,785
24,965
24,574
24,57424,965-19,785-54,921-30,015-48,5827,231
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
0
0
0
0
0
0
1
1000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue137,064
Cost of Revenue-30,946
Gross Profit106,118106,118
 
Operating Income (+$)
Gross Profit106,118
Operating Expense-149,877
Operating Income-12,813-43,759
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense149,8770
 
Net Interest Income (+$)
Interest Income-
Interest Expense-3,431
Other Finance Cost-2,404
Net Interest Income-1,027
 
Pretax Income (+$)
Operating Income-12,813
Net Interest Income-1,027
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-12,454-12,813
EBIT - interestExpense = -3,431
-12,454
-9,023
Interest Expense3,431
Earnings Before Interest and Taxes (EBIT)--9,023
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-12,454
Tax Provision-0
Net Income From Continuing Ops-12,454-12,454
Net Income-12,454
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,027
 

Technical Analysis of Aspira Pathlab & Diagnostics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aspira Pathlab & Diagnostics Ltd. The general trend of Aspira Pathlab & Diagnostics Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aspira Pathlab & Diagnostics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aspira Pathlab & Diagnostics Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 39.74 < 40.90 < 43.95.

The bearish price targets are: 28.10 > 25.00 > 22.76.

Tweet this
Aspira Pathlab & Diagnostics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aspira Pathlab & Diagnostics Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aspira Pathlab & Diagnostics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aspira Pathlab & Diagnostics Ltd. The current macd is -0.5140506.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aspira Pathlab & Diagnostics Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Aspira Pathlab & Diagnostics Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Aspira Pathlab & Diagnostics Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Aspira Pathlab & Diagnostics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAspira Pathlab & Diagnostics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aspira Pathlab & Diagnostics Ltd. The current adx is 19.62.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aspira Pathlab & Diagnostics Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Aspira Pathlab & Diagnostics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aspira Pathlab & Diagnostics Ltd. The current sar is 29.64.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Aspira Pathlab & Diagnostics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aspira Pathlab & Diagnostics Ltd. The current rsi is 45.17. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Aspira Pathlab & Diagnostics Ltd Daily Relative Strength Index (RSI) ChartAspira Pathlab & Diagnostics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aspira Pathlab & Diagnostics Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aspira Pathlab & Diagnostics Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Aspira Pathlab & Diagnostics Ltd Daily Stochastic Oscillator ChartAspira Pathlab & Diagnostics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aspira Pathlab & Diagnostics Ltd. The current cci is -49.54367666.

Aspira Pathlab & Diagnostics Ltd Daily Commodity Channel Index (CCI) ChartAspira Pathlab & Diagnostics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aspira Pathlab & Diagnostics Ltd. The current cmo is -11.77708202.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Aspira Pathlab & Diagnostics Ltd Daily Chande Momentum Oscillator (CMO) ChartAspira Pathlab & Diagnostics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aspira Pathlab & Diagnostics Ltd. The current willr is -75.08591065.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Aspira Pathlab & Diagnostics Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Aspira Pathlab & Diagnostics Ltd Daily Williams %R ChartAspira Pathlab & Diagnostics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aspira Pathlab & Diagnostics Ltd.

Aspira Pathlab & Diagnostics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aspira Pathlab & Diagnostics Ltd. The current atr is 3.17752434.

Aspira Pathlab & Diagnostics Ltd Daily Average True Range (ATR) ChartAspira Pathlab & Diagnostics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aspira Pathlab & Diagnostics Ltd. The current obv is -789,333.

Aspira Pathlab & Diagnostics Ltd Daily On-Balance Volume (OBV) ChartAspira Pathlab & Diagnostics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aspira Pathlab & Diagnostics Ltd. The current mfi is 51.69.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Aspira Pathlab & Diagnostics Ltd Daily Money Flow Index (MFI) ChartAspira Pathlab & Diagnostics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aspira Pathlab & Diagnostics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Aspira Pathlab & Diagnostics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aspira Pathlab & Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.165
Ma 20Greater thanMa 5032.490
Ma 50Greater thanMa 10033.398
Ma 100Greater thanMa 20036.031
OpenGreater thanClose34.750
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Aspira Pathlab & Diagnostics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Aspira Pathlab & Diagnostics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aspira Pathlab & Diagnostics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aspira Pathlab & Diagnostics Ltd

I send you an email if I find something interesting about Aspira Pathlab & Diagnostics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Aspira Pathlab & Diagnostics Ltd.

Receive notifications about Aspira Pathlab & Diagnostics Ltd in your mailbox!